Pyrrolidine ether derivatives as NK3 receptor antagonists

Details for Australian Patent Application No. 2009256680 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Ratni, Hasane; Nettekoven, Matthias; Knust, Henner; Jablonski, Philippe; Riemer, Claus; Limberg, Anja; Kawasaki, Kenichi

Agent Spruson & Ferguson

Pub. Number AU-A-2009256680

PCT Pub. Number WO2009/150110

Priority 08157952.6 10.06.08 EP

Filing date 8 June 2009

Wipo publication date 17 December 2009

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/150110 Priority application(s): WO2009/150110

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009256688-Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2methylphenyl)carbonyl]amino}-3-methylphenyl )acetic acid

2009256679-Imidazolidine derivatives